Skip to main content
. 2020 Sep 11;15(9):e0239131. doi: 10.1371/journal.pone.0239131

Table 2. Regions targeted for Massively Parallel Sequencing (MPS).

Targeted position (hg19) Target gene Targeted bases (kb) Percentage covered (probe design)
chr5:33924931–33986419 SLC45A2 50 88%
chr6:380958–421773 IRF4 41 95%
chr9:12668608–12710455 TYRP1 37 87%
chr11:88547978–89046386 TYR 238 78%
chr14:92755906–92967828 SLC24A4 177 88%
chr15:28344106–28369332 OCA2-HERC2 20 87%
chr15:48394145–48434879 SLC24A5 39 95%